Potential albumin-based antioxidant nanoformulations for ocular protection against oxidative stress

Pharmaceutics

Volumn 11, Issue 7, 2019, Pages

  Kim, Daseul ^a   Maharjan, Pooja ^a   Jin, Minki ^a   Park, Taehoon ^b   Maharjan, Anjila ^a   Amatya, Reeju ^b   Yang, Jaewook ^a,c   Min, Kyoung Ah ^a   Shin, Meong Cheol ^b  

^a Inje University   (South Korea)

^b Gyeongsang National University   (South Korea)

^c Inje University College of Medicine   (South Korea)

Author keywords

Antioxidant; Bovine serum albumin; Cornea; Drug transport; Ophthalmic formulation; Retinal pigmented epithelium

Indexed keywords

ANTIOXIDANT; BOVINE SERUM ALBUMIN; CURCUMIN; NANOPARTICLE; NANOSPHERE; POLYPHENOL DERIVATIVE; REACTIVE OXYGEN METABOLITE; ROSMARINIC ACID; URSOLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; EPITHELIUM CELL; EYE PROTECTION; HUMAN; HUMAN TISSUE; NANOENCAPSULATION; NEW ZEALAND WHITE (RABBIT); NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PROTEIN SYNTHESIS INHIBITION; RETINAL PIGMENT EPITHELIUM; ZETA POTENTIAL;

EID: 85070999356     PISSN: None     EISSN: 19994923     Source Type: Journal    
DOI: 10.3390/pharmaceutics11070297     Document Type: Article

References (37)

1. Achouri, D.; Alhanout, K.; Piccerelle, P.; Andrieu, V. Recent advances in ocular drug delivery. Drug Dev. Ind. Pharm. 2013, 39, 1599–1617. [CrossRef] [PubMed]
2. Maharjan, P.; Cho, K.H.; Maharjan, A.; Shin, M.C.; Moon, C.; Min, K.A. Pharmaceutical challenges and perspectives in developing ophthalmic drug formulations. J. Pharm. Investig. 2019, 49, 215–228. [CrossRef]
3. Beatty, S.; Koh, H.; Phil, M.; Henson, D.; Boulton, M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 2000, 45, 115–134. [CrossRef]
4. Madsen-Bouterse, S.A.; Kowluru, R.A. Oxidative stress and diabetic retinopathy: Pathophysiological mechanisms and treatment perspectives. Rev. Endocr. Metab. Disord. 2008, 9, 315–327. [CrossRef] [PubMed]
5. Lee, H.; Shim, W.; Kim, C.E.; Choi, S.Y.; Lee, H.; Yang, J. Therapeutic efficacy of nanocomplex of poly(ethylene glycol) and catechin for dry eye disease in a mouse model. Investig. Ophthalmol. Vis. Sci. 2017, 58, 1682–1691. [CrossRef] [PubMed]
6. Fujisawa, S.; Atsumi, T.; Ishihara, M.; Kadoma, Y. Cytotoxicity, ROS-generation activity and radical-scavenging activity of curcumin and related compounds. Anticancer Res. 2004, 24, 563–570. [PubMed]
7. Deng, R.; Hua, X.; Li, J.; Chi, W.; Zhang, Z.; Lu, F.; Zhang, L.; Pflugfelder, S.C.; Li, D.Q. Oxidative stress markers induced by hyperosmolarity in primary human corneal epithelial cells. PLoS ONE 2015, 10, e0126561. [CrossRef]
8. 2: Regulation of peroxiredoxin, catalase, and glutathione peroxidase via post-translational modification. Antioxid. Redox Signal. 2005, 7, 619–626. [CrossRef]
9. Casanova, F.; Estevinho, B.N.; Santos, L. Preliminary studies of rosmarinic acid microencapsulation with chitosan and modified chitosan for topical delivery. Powder Technol. 2016, 297, 44–49. [CrossRef]
10. Yang, L.; Sun, Z.; Zu, Y.; Zhao, C.; Sun, X.; Zhang, Z.; Zhang, L. Physicochemical properties and oral bioavailability of ursolic acid nanoparticles using supercritical anti-solvent (SAS) process. Food Chem. 2012, 132, 319–325. [CrossRef]
11. Choi, Y.H.; Han, H.-K. Nanomedicines: Current status and future perspectives in aspect of drug delivery and pharmacokinetics. J. Pharm. Investig. 2018, 48, 43–60. [CrossRef] [PubMed]
12. Sahoo, S.K.; Dilnawaz, F.; Krishnakumar, S. Nanotechnology in ocular drug delivery. Drug Discov. Today 2008, 13, 144–151. [CrossRef] [PubMed]
13. Manchanda, S.; Sahoo, P.K.; Hussein, Z.M. Fabrication and characterization of mucoadhesive topical nanoformulations of dorzolamide HCl for ocular hypertension. J. Pharm. Investig. 2018, 48, 323–332. [CrossRef]
14. Yewale, C.; Baradia, D.; Patil, S.; Bhatt, P.; Amrutiya, J.; Gandhi, R.; Kore, G.; Misra, A. Docetaxel loaded immunonanoparticles delivery in EGFR overexpressed breast carcinoma cells. J. Drug Deliv. Sci. Technol. 2018, 45, 334–345. [CrossRef]
15. Elzoghby, A.O.; Samy, W.M.; Elgindy, N.A. Protein-based nanocarriers as promising drug and gene delivery systems. J. Control. Release 2012, 161, 38–49. [CrossRef] [PubMed]
16. Elzoghby, A.O.; Samy, W.M.; Elgindy, N.A. Albumin-based nanoparticles as potential controlled release drug delivery systems. J. Control. Release 2012, 157, 168–182. [CrossRef]
17. Lou, J.; Hu, W.; Tian, R.; Zhang, H.; Jia, Y.; Zhang, J.; Zhang, L. Optimization and evaluation of a thermoresponsive ophthalmic in situ gel containing curcumin-loaded albumin nanoparticles. Int. J. Nanomed. 2014, 9, 2517–2525.
18. Kim, T.H.; Jiang, H.H.; Youn, Y.S.; Park, C.W.; Tak, K.K.; Lee, S.; Kim, H.; Jon, S.; Chen, X.; Lee, K.C.; et al. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Int. J. Pharm. 2011, 403, 285–291. [CrossRef]
19. Jithan, A.; Madhavi, K.; Madhavi, M.; Prabhakar, K. Preparation and characterization of albumin nanoparticles encapsulating curcumin intended for the treatment of breast cancer. Int. J. Pharm. Investig. 2011, 1, 119–125. [CrossRef]
20. Sadeghi, R.; Moosavi-Movahedi, A.; Emam-Jomeh, Z.; Kalbasi, A.; Razavi, S.; Karimi, M.; Kokini, J. The effect of different desolvating agents on BSA nanoparticle properties and encapsulation of curcumin. J. Nanopart. Res. 2014, 16, 2565. [CrossRef]
21. Castro Frabel do Nascimento, T.; Meza Casa, D.; Facco Dalmolin, L.; Cristina de Mattos, A.; Maissar Khalil, N.; Mara Mainardes, R. Development and validation of an HPLC method using fluorescence detection for the quantitative determination of curcumin in PLGA and PLGA-PEG nanoparticles. Curr. Pharm. Anal. 2012, 8, 324–333. [CrossRef]
22. Troncoso, N.; Sierra, H.; Carvajal, L.; Delpiano, P.; Günther, G. Fast high performance liquid chromatography and ultraviolet–visible quantification of principal phenolic antioxidants in fresh rosemary. J. Chromatogr. A 2005, 1100, 20–25. [CrossRef]
23. Taralkar, S.; Chattopadhyay, S. A HPLC Method for determination of ursolic acid and betulinic acids from their methanolic extracts of Vitex Negundo Linn. J. Anal. Bioanal. Tech. 2012, 3, 1000134. [CrossRef]
24. Bhatt, P.; Lalani, R.; Vhora, I.; Patil, S.; Amrutiya, J.; Misra, A.; Mashru, R. Liposomes encapsulating native and cyclodextrin enclosed paclitaxel: Enhanced loading efficiency and its pharmacokinetic evaluation. Int. J. Pharm. 2018, 536, 95–107. [CrossRef] [PubMed]
25. Moreno-Bautista, G.; Tam, K.C. Evaluation of dialysis membrane process for quantifying the in vitro drug-release from colloidal drug carriers. Colloids Surf. A Physicochem. Eng. Asp. 2011, 389, 299–303. [CrossRef]
26. −∆∆Ct calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts. Diagn. Mol. Patho. 2006, 15, 56–61. [CrossRef]
27. Parakh, D.R.; Patil, M.P.; Sonawane, S.S.; Kshirsagar, S.J. Application of factorial design approach in development and evaluation of self microemulsifying drug delivery system (SMEDDS) of mebendazole. J. Pharm. Investig. 2017, 47, 507–519. [CrossRef]
28. Yallapu, M.M.; Jaggi, M.; Chauhan, S.C. β-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf. B Biointerfaces 2010, 79, 113–125. [CrossRef]
29. Luu, T.D.; Lee, B.-J.; Tran, P.H.; Tran, T.T. Modified sprouted rice for modulation of curcumin crystallinity and dissolution enhancement by solid dispersion. J. Pharm. Investig. 2019, 49, 127–134. [CrossRef]
30. Qing, H.; Yanlin, H.; Fenlin, S.; Zuyi, T. Effects of pH and metal ions on the conformation of bovine serum albumin in aqueous solution An attenuated total reflection (ATR) FTIR spectroscopic study. Spectrochim. Acta A Mol. Biomol. Spectrosc. 1996, 52, 1795–1800. [CrossRef]
31. Nosrati, H.; Sefidi, N.; Sharafi, A.; Danafar, H.; Kheiri Manjili, H. Bovine Serum Albumin (BSA) coated iron oxide magnetic nanoparticles as biocompatible carriers for curcumin-anticancer drug. Bioorg. Chem. 2018, 76, 501–509. [CrossRef]
32. Van Reyk, D.M.; Gillies, M.C.; Davies, M.J. The retina: Oxidative stress and diabetes. Redox Rep. 2003, 8, 187–192. [CrossRef] [PubMed]
33. D’Angio, C.T.; Finkelstein, J.N. Oxygen regulation of gene expression: A study in opposites. Mol. Genet. Metab. 2000, 71, 371–380. [CrossRef] [PubMed]
34. Kortuem, K.; Geiger, L.K.; Levin, L.A. Differential susceptibility of retinal ganglion cells to reactive oxygen species. Investig. Ophthalmol. Vis. Sci. 2000, 41, 3176–3182.
35. Jarrett, S.G.; Lin, H.; Godley, B.F.; Boulton, M.E. Mitochondrial DNA damage and its potential role in retinal degeneration. Prog. Retin Eye Res. 2008, 27, 596–607. [CrossRef]
36. Jin, G.F.; Hurst, J.S.; Godley, B.F. Hydrogen peroxide stimulates apoptosis in cultured human retinal pigment epithelial cells. Curr. Eye Res. 2001, 22, 165–173. [CrossRef] [PubMed]
37. ′-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation. Biochem. Pharmacol. 2003, 65, 1575–1582. [CrossRef]